Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5699060 | Clinical Oncology | 2010 | 15 Pages |
Abstract
Inverse-planned IMRT maintains parotid saliva production and reduces acute and late xerostomia during radiotherapy for locally advanced head and neck cancer, reduces late rectal toxicity in prostate cancer patients allowing safe dose escalation and seems to reduce toxicity in several other tumour sites. Forward-planned IMRT reduces acute toxicity and improves late clinician-assessed cosmesis compared with conventional tangential breast radiotherapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J. Staffurth, on behalf of the Radiotherapy Development Board on behalf of the Radiotherapy Development Board,